









Markets
/
Stocks
/
nasdaq-lfwd
/

Lifeward Ltd

LFWD

0.570USD

+0.027+5.01%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

9.61MMarket Cap

LossP/E TTM



Lifeward Ltd

0.570

+0.027+5.01%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Lifeward Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Lifeward Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 103 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.25.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Lifeward Ltd's Score

Industry at a Glance

Industry Ranking

103 / 205

Overall Ranking

280 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Lifeward Ltd Highlights

StrengthsRisks

Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 365.67% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 25.66M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 25.66M.

Overvalued

The company’s latest PE is -0.20, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 877.28K shares, decreasing 48.97% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 131.71K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.66.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

7.250

Target Price

+1235.67%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Lifeward Ltd is 6.34, ranking 160 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 6.20M, representing a year-over-year increase of 1.09%, while its net profit experienced a year-over-year increase of 2.79%.

Score

Industry at a Glance

Previous score

6.34

Change



Financials

5.89

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.83

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.94

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.98

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Lifeward Ltd's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Lifeward Ltd is 8.18, ranking 44 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.20, which is -15.71% below the recent high of -0.17 and -9941.71% above the recent low of -19.69.

Score

Industry at a Glance

Previous score

8.18

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 103/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Lifeward Ltd is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 4.50, with a high of 10.00 and a low of 1.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

7.250

Target Price

+1235.67%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Lifeward Ltd

LFWD

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Lifeward Ltd is 6.06, ranking 165 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.70 and the support level at 0.48, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.87

Change

0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.026

Sell

RSI(14)

40.300

Neutral

STOCH(KDJ)(9,3,3)

18.097

Neutral

ATR(14)

0.043

Low Volatility

CCI(14)

-88.257

Neutral

Williams %R

78.657

Sell

TRIX(12,20)

-0.374

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

0.567

Buy

MA10

0.603

Sell

MA20

0.641

Sell

MA50

0.643

Sell

MA100

0.648

Sell

MA200

0.788

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Lifeward Ltd is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 4.80%, representing a quarter-over-quarter increase of 68.46%. The largest institutional shareholder is James Simons, holding a total of 131.71K shares, representing 0.72% of shares outstanding, with 0.58% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Citadel Advisors LLC

214.01K

Renaissance Technologies LLC

Star Investors

131.71K

+43.31%

Susquehanna International Group, LLP

116.87K

+266.09%

The Lind Partners, LLC

94.52K

-88.98%

Lynch (Jeannine)

77.74K

+180.23%

Swinford (Michael)

74.01K

+13.80%

Turk (Joseph E Jr)

51.08K

+54.17%

Two Sigma Investments, LP

45.66K

+119.72%

XTX Markets LLC

41.08K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Lifeward Ltd is 2.01, ranking 167 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.14. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.